Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
D000818:Animals; D001284:Atrophy / Q000139:chemically induced; D002208:Caproates / Q000627:therapeutic use; D002784:Cholesterol / Q000008:administration & dosage; D004054:Diethylstilbestrol / Q000008:administration & dosage; D004195:Disease Models, Animal; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D011467:Prostate / Q000187:drug effects / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D001743:Urinary Bladder / Q000473:pathology; D001748:Urinary Bladder Neck Obstruction / Q000188:drug therapy* / Q000209:etiology; D014649:Vas Deferens / Q000187:drug effects
D002208:Caproates; D006908:Hydroxyprogesterones; D004054:Diethylstilbestrol; D002784:Cholesterol